PHARMACEUTICAL CONFERENCES |
|
| |
Pharma Conference Inc produces continuing education programs for the Pharmaceutical, Blood and Tissue industries in the U.S. and around the world. Pharma Conference Inc partners with The University of Rhode Island College of Pharmacy for all of its Good Manufacturing Practice (GMP) programs for professionals involved in regulatory affairs, quality assurance and manufacturing.
Register for one of our conferences today.
|
| |
To view a brochure click on the link next to the conference title.

You will need Adobe™ Acrobat Reader. If you don't have it, you can download it free. |
|
| |
| |
| |
 |
|
May 11 – 12, 2010 * Bethesda, Maryland |
| |
FDA and PAT for Pharma Manufacturing: FDA-Partnering with Industry...a joint FDA/URI College of Pharmacy conference |
| |
The Food and Drug Administration (FDA) is pleased to announce this joint conference with the University of Rhode Island (URI) College of Pharmacy. This 2-day conference is co-sponsored by FDA, the URI College of Pharmacy, and Pharma Conference Inc. The conference is intended to disseminate current and accurate information on Process Analytical Technology (PAT) to the pharmaceutical industry and create a venue for dialogue between the PAT users and FDA. The conference will feature FDA’s perspective on where PAT will be applicable in the manufacturing process and FDA’s current thinking on how PAT will be reviewed in new and abbreviated new drug applications, amendments, or supplements to an application.
|
| |
Register for this Conference View Brochure |
|
| |
| |
| |
| |
 |
|
May 18 – 19, 2010 * New Brunswick, New Jersey |
| |
12th Annual FDA and the Current Challenges of GMPs |
| |
This year’s conference focuses on compliance expectations. What is FDA working on? New
guidances, recent enforcement actions, 483 issues and many other issues emanating from the Center for
Drug Evaluation and Research and the Office of Regulatory Affairs will be covered. The topics in this year’s conference are taken from some of the most frequently listed regulatory observations following FDA inspections and presenting the subjects in a manner that will help you adopt measures to comply with regulatory expectations and prevent your being cited for similar violations of the GMPs.
|
| |
Register for this Conference View Brochure |
|
|